These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 22163166)
1. Novel mucus-penetrating liposomes as a potential oral drug delivery system: preparation, in vitro characterization, and enhanced cellular uptake. Li X; Chen D; Le C; Zhu C; Gan Y; Hovgaard L; Yang M Int J Nanomedicine; 2011; 6():3151-62. PubMed ID: 22163166 [TBL] [Abstract][Full Text] [Related]
2. Comparative study of Pluronic(®) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats. Chen D; Xia D; Li X; Zhu Q; Yu H; Zhu C; Gan Y Int J Pharm; 2013 Jun; 449(1-2):1-9. PubMed ID: 23583840 [TBL] [Abstract][Full Text] [Related]
3. Mucus adhesion- and penetration-enhanced liposomes for paclitaxel oral delivery. Liu Y; Yang T; Wei S; Zhou C; Lan Y; Cao A; Yang J; Wang W Int J Pharm; 2018 Feb; 537(1-2):245-256. PubMed ID: 29288808 [TBL] [Abstract][Full Text] [Related]
4. The modulation of the permeability and the cellular uptake of liposome by stable anchoring of lipid-conjugated pluronic on liposome. Kim JC; Chungt YI; Kim YH; Tae G J Biomed Nanotechnol; 2014 Jan; 10(1):100-8. PubMed ID: 24724502 [TBL] [Abstract][Full Text] [Related]
5. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles. Li X; Guo S; Zhu C; Zhu Q; Gan Y; Rantanen J; Rahbek UL; Hovgaard L; Yang M Biomaterials; 2013 Dec; 34(37):9678-87. PubMed ID: 24016855 [TBL] [Abstract][Full Text] [Related]
6. Pluronic F127-modified liposome-containing tacrolimus-cyclodextrin inclusion complexes: improved solubility, cellular uptake and intestinal penetration. Zhu Q; Guo T; Xia D; Li X; Zhu C; Li H; Ouyang D; Zhang J; Gan Y J Pharm Pharmacol; 2013 Aug; 65(8):1107-17. PubMed ID: 23837579 [TBL] [Abstract][Full Text] [Related]
7. The construction and characterization of hybrid paclitaxel-in-micelle-in-liposome systems for enhanced oral drug delivery. Li Y; Chen Z; Cui Y; Zhai G; Li L Colloids Surf B Biointerfaces; 2017 Dec; 160():572-580. PubMed ID: 29028605 [TBL] [Abstract][Full Text] [Related]
8. Interaction of cruciferin-based nanoparticles with Caco-2 cells and Caco-2/HT29-MTX co-cultures. Akbari A; Lavasanifar A; Wu J Acta Biomater; 2017 Dec; 64():249-258. PubMed ID: 29030304 [TBL] [Abstract][Full Text] [Related]
9. PEGylated Nanoemulsions for Oral Delivery: Role of the Inner Core on the Final Fate of the Formulation. Santander-Ortega MJ; Plaza-Oliver M; Rodríguez-Robledo V; Castro-Vázquez L; Villaseca-González N; González-Fuentes J; Cano EL; Marcos P; Lozano MV; Arroyo-Jiménez MM Langmuir; 2017 May; 33(17):4269-4279. PubMed ID: 28391698 [TBL] [Abstract][Full Text] [Related]
10. Oral mucus-penetrating PEGylated liposomes to improve drug absorption: Differences in the interaction mechanisms of a mucoadhesive liposome. Yamazoe E; Fang JY; Tahara K Int J Pharm; 2021 Jan; 593():120148. PubMed ID: 33290871 [TBL] [Abstract][Full Text] [Related]
11. Engineering of a novel pluronic F127/graphene nanohybrid for pH responsive drug delivery. Hu H; Yu J; Li Y; Zhao J; Dong H J Biomed Mater Res A; 2012 Jan; 100(1):141-8. PubMed ID: 21997951 [TBL] [Abstract][Full Text] [Related]
12. Recent progress in biomedical applications of Pluronic (PF127): Pharmaceutical perspectives. Akash MS; Rehman K J Control Release; 2015 Jul; 209():120-38. PubMed ID: 25921088 [TBL] [Abstract][Full Text] [Related]
13. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles. Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754 [TBL] [Abstract][Full Text] [Related]
14. Pulmonary delivery of mucus-traversing PF127-modified silk fibroin nanoparticles loading with quercetin for lung cancer therapy. Tang Y; Zhang L; Sun R; Luo B; Zhou Y; Zhang Y; Liang Y; Xiao B; Wang C Asian J Pharm Sci; 2023 Jul; 18(4):100833. PubMed ID: 37635802 [TBL] [Abstract][Full Text] [Related]
15. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport. Jin Y; Song Y; Zhu X; Zhou D; Chen C; Zhang Z; Huang Y Biomaterials; 2012 Feb; 33(5):1573-82. PubMed ID: 22093292 [TBL] [Abstract][Full Text] [Related]
16. Cysteine modified and bile salt based micelles: preparation and application as an oral delivery system for paclitaxel. Xu W; Fan X; Zhao Y; Li L Colloids Surf B Biointerfaces; 2015 Apr; 128():165-171. PubMed ID: 25747310 [TBL] [Abstract][Full Text] [Related]
17. Mucus-penetrating nanoparticles: Promising drug delivery systems for the photodynamic therapy of intestinal cancer. Anderski J; Mahlert L; Mulac D; Langer K Eur J Pharm Biopharm; 2018 Aug; 129():1-9. PubMed ID: 29778525 [TBL] [Abstract][Full Text] [Related]
18. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications. Lin JJ; Chen JS; Huang SJ; Ko JH; Wang YM; Chen TL; Wang LF Biomaterials; 2009 Oct; 30(28):5114-24. PubMed ID: 19560199 [TBL] [Abstract][Full Text] [Related]
19. A functional drug delivery platform for targeting and imaging cancer cells based on Pluronic F127. Zhang D; Tao L; Zhao H; Yuan H; Lan M J Biomater Sci Polym Ed; 2015; 26(8):468-82. PubMed ID: 25780935 [TBL] [Abstract][Full Text] [Related]
20. Improved oral bioavailability of breviscapine via a Pluronic P85-modified liposomal delivery system. Zhou Y; Ning Q; Yu DN; Li WG; Deng J J Pharm Pharmacol; 2014 Jul; 66(7):903-11. PubMed ID: 24697705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]